Cotransplantation with specific populations of spina bifida bone marrow stem/progenitor cells enhances urinary bladder regeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 10, 2013, Pages 4003-4008

  Sharma, Arun K ^a,b,c   Bury, Matthew I ^a   Fuller, Natalie J ^a   Marks, Andrew J ^a   Kollhoff, David M ^d   Rao, Manoj V ^d   Hota, Partha V ^e   Matoka, Derek J ^d   Edassery, Seby L ^f   Thaker, Hatim ^a   Sarwark, John F ^a   Janicki, Joseph A ^a   Ameer, Guillermo A ^b,c,g   Cheng, Earl Y ^a,b,c  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g Northwestern University   (United States)

Author keywords

Angiogenesis; Biocompatible polymer; Cell seeded matrix; Multipotent; Organ repair

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; GAMMA TUBULIN;

ANGIOGENESIS; ARTICLE; BLADDER; BLADDER MUSCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL DYSRAPHISM; TISSUE ENGINEERING;

ADOLESCENT; ANIMALS; CHILD; CITRATES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE REGENERATION; POLYMERS; RATS; RATS, NUDE; REGENERATION; SPINAL DYSRAPHISM; TISSUE ENGINEERING; TISSUE SCAFFOLDS; URINARY BLADDER; URINARY BLADDER, NEUROGENIC;

EID: 84874610958     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1220764110     Document Type: Article

References (36)

1. Greene ND, Stanier P, Copp AJ (2009) Genetics of human neural tube defects. Hum Mol Genet 18(R2):R113-R129.
2. Bebbington MW, Danzer E, Johnson MP, Adzick NS (2011) Open fetal surgery for myelomeningocele. Prenat Diagn 31(7):689-694.
3. Clayton DB, Brock JW, Joseph DB (2010) Urologic management of spina bifida. Dev Disabil Res Rev 16(1):88-95.
4. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367(9518):1241-1246.
5. Guven A, Onal B, Kogan BA (2006) Spontaneous bladder perforations following augmentation cystoplasty in children. Nat Clin Pract Urol 3(11):584-585.
6. Flood HD, et al. (1995) Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn 14(4):297-309.
7. Austin JC (2008) Long-term risks of bladder augmentation in pediatric patients. Curr Opin Urol 18(4):408-412.
8. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89(7): 2804-2808.
9. Losordo DW, et al. (2007) Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 115(25):3165-3172.
10. Pittenger MF, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147.
11. Ishikane S, et al. (2008) Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26(10):2625-2633.
12. Heinrich M, Oberbach A, Schlichting N, Stolzenburg J-U, Neuhaus J (2011) Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS ONE 6(6):e20792.
13. Sharma AK, et al. (2010) Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1, 8-octanediolco- citrate) based thin films. Biomaterials 31(24):6207-6217.
14. Hoogduijn MJ, Cheng A, Genever PG (2009) Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev 18(1):103-112.
15. Sharma AK, et al. (2009) Defined populations of bone marrow derived mesenchymal stem and endothelial progenitor cells for bladder regeneration. J Urol 182(4, Suppl): 1898-1905.
16. Nagatomi J, Toosi KK, Grashow JS, Chancellor MB, Sacks MS (2005) Quantification of bladder smooth muscle orientation in normal and spinal cord injured rats. Ann Biomed Eng 33(8):1078-1089.
17. Takeda K, et al. (1998) Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model. Eur J Radiol 26(3):290-296.
18. Shin K, et al. (2011) Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472(7341):110-114.
19. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R (1998) Role of members of the Wnt gene family in human hematopoiesis. Blood 92(9):3189-3202.
20. Cathey L, Lee KY, Holder W (2007) D, Mooney DJ, Halberstadt CR. Principles of Tissue Engineering, eds Lanza R, Langer R, Vacanti J (Elsevier, New York), 3rd Ed, pp 528-530.
21. Stegemann JP, Kaszuba SN, Rowe SL (2007) Review: Advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng 13(11):2601-2613.
22. Sahoo S, et al. (2011) Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 109(7):724-728.
23. Losordo DW, et al.; ACT34-CMI Investigators (2011) Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 109(4):428-436.
24. Bexell D, et al. (2009) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17(1):183-190.
25. Scheubel RJ, et al. (2010) Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting. Int J Cardiol 139(2):134-141.
26. Tei K, et al. (2008) Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells 26(3):819-830.
27. Murphy EA, et al. (2008) Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci USA 105(27):9343-9348.
28. Frontini MJ, et al. (2011) Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat Biotechnol 29(5):421-427.
29. Xiao CG, et al. (2003) An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol 170(4 Pt 1):1237-1241.
30. Steidl U, et al. (2004) Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood 104(1):81-88.
31. Bracci-Laudiero L, et al. (2003) CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol 136(1-2): 130-139.
32. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR (2000) Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290(5497):1779-1782.
33. Spiegel A, et al. (2007) Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 8(10):1123-1131.
34. Gao J, et al. (2006) A neuroinductive biomaterial based on dopamine. Proc Natl Acad Sci USA 103(45):16681-16686.
35. Guys JM, et al. (2004) Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol 172(4 Pt 2):1673-1676.
36. Choi E, et al. (2012) Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: A 10-year experience. J PediatrUrol S1477- 5131(12)00257-4.